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Background
By exploiting the paramagnetic properties of deoxyhemo-
globin, blood oxygen level-dependent (BOLD) MRI can
be used to determine myocardial oxygenation. In this
study involving human subjects, we used BOLD and per-
fusion MRI at 3 Tesla to investigate the relationship
between coronary artery stenosis, myocardial perfusion
and tissue oxygenation. We sought (1) to define a thresh-
old for BOLD MRI to identify myocardium subtended by
coronary stenosis, and (2) to determine its diagnostic
accuracy in patients with suspected CAD.
Methods
Subjects were studied at 3 Tesla (Trio, Siemens Medical
Solutions). Ischemic thresholds for BOLD and first-pass
perfusion imaging were determined in 25 patients (age 61
± 7) with known CAD and 20 normal volunteers (age 53
± 7). These thresholds were then applied in a consecutive
series of 60 patients with suspected CAD, in whom diag-
nostic angiography was scheduled to investigate exer-
tional chest pain.
For BOLD MRI, mid-ventricular short-axis images were
acquired at rest and stress (4-5 minutes intravenous ade-
nosine, 140 μg/kg/min) using a T2-prepared SSFP
sequence (echo time 1.43 ms, repetition time 2.86 ms, T2
preparation time 40 ms, matrix 168 × 192, slice thickness
8 mm, flip angle 44°). First-pass perfusion imaging was
then performed in the same slice locations following
intravenous Gadolinium-DTPA bolus injections (0.04
mmol/kg, Gadodiamide, Omniscan™, GE Healthcare)
using a T1-weighted fast gradient echo sequence (echo
time 1.04 ms, repetition time 2 ms, voxel size 2.1 × 2.6 ×
8 mm3). Absolute quantification of perfusion was per-
formed using model-independent deconvolution. For
BOLD analysis, stress signal intensity (SI) was indexed to
resting SI using a segmental approach. Quantitative coro-
nary angiography was used to evaluate segmental coro-
nary stenosis: a reduction in luminal diameter of > 50%
was deemed significant.
Results
In the validation arm, taking QCA as the gold standard,
cut-off values to define ischemic segments were derived
for hyperemic myocardial blood flow (<2.1 ml/min/g -
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AUC 0.72) and BOLD SI change (<5.2% - AUC 0.64). In
the prospective arm, the complete imaging protocol was
performed in 57 individuals (age 61 ± 9, CAD prevalence
68%). On a per subject basis, applying the BOLD SI
threshold provided diagnostic accuracy 83%, sensitivity
94% and specificity 56% for the detection of CAD (com-
pared with 84%, 95% and 61%, respectively for perfusion
imaging). On a per subject basis, agreement between
BOLD and perfusion imaging was 81%.
Conclusion
BOLD imaging at 3 Tesla is comparable with first-pass per-
fusion imaging, and yields favorable diagnostic accuracy
in the detection of significant CAD.Page 2 of 2
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